Trisomy 13 and the risk of gestational hypertensive disorders: a population-based study

The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Sarah K Dotters-KatzAaron B Caughey

Abstract

To describe the rate and severity of gestational hypertensive disorders (GHDs) in pregnancies complicated by trisomy 13 (T13). Retrospective cohort study of singleton deliveries in California from 2005 to 2008 using vital statistics and ICD-9 data. We were interested in gestational hypertension (gHTN), preeclampsia with and without severe features (sPREX and PREX), and gestational age at delivery. Pregnancies and maternal complications affected by prenatally diagnosed T13 were compared to unaffected pregnancies. Regression models were used to compute adjusted odds ratios for pregnancy outcomes by T13 status. Of the 2,029,004 deliveries, 142 women had prenatally diagnosed T13. A diagnosis of GHD occurred in 26.8% of the T13 pregnancies versus 6% of the non-T13 pregnancies (p < .001). This remained true for gHTN (9.2% versus 3.2%, p=.001), PREX (12% versus 2.2%, p < .001), and sPREX (8.5% versus 0.9%, p < .001). After adjusting for confounders, T13 pregnancies were 6.3-times more likely to be affected by GHD, and 12.5-times more likely to have sPREX. Delivery <37 and <32 weeks in the setting of GHD was 14.1-times and 11.2-times likely among women with T13. Women with T13 pregnancies were significantly more likely to have gHTN, pr...Continue Reading

References

Nov 1, 1992·British Journal of Obstetrics and Gynaecology·J F Tuohy, D K James
Aug 22, 1987·Lancet·P A BoydC Redman
Oct 31, 1987·Lancet·C BowerB N Walters
Dec 1, 1987·Journal of Medical Genetics·P A JacobsN Takaesu
Mar 26, 2008·American Journal of Medical Genetics. Part a·Joan K Morris, George M Savva
Apr 22, 2011·American Journal of Obstetrics and Gynecology·Michelle SilasiIsaac E Stillman
Oct 13, 2011·American Journal of Medical Genetics. Part a·Deborah Bruns
Oct 13, 2011·American Journal of Medical Genetics. Part a·Jun MaedaToshio Nakanishi
Oct 25, 2011·Obstetrical & Gynecological Survey·Sarah Dotters-KatzR Phillips Heine
May 18, 2016·Obstetrical & Gynecological Survey·Sarah K Dotters-KatzRobert A Strauss
Jul 28, 2016·JAMA : the Journal of the American Medical Association·Katherine E NelsonAstrid Guttmann

❮ Previous
Next ❯

Citations

Nov 7, 2019·Current Opinion in Obstetrics & Gynecology·Paola QuaresimaElena Greco
Sep 27, 2019·Human Genetics·Giulia F Del GobboWendy P Robinson
Feb 27, 2021·American Journal of Perinatology·Hanan H AfifiAngie M S Tosson
May 31, 2021·Lancet·Lucy C ChappellStephen Tong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Obstetrics, Gynecology, and Reproductive Biology
Sarah K Dotters-KatzAaron B Caughey
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Angie C JelinAaron B Caughey
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine
Muktar H AliyuHamisu M Salihu
© 2022 Meta ULC. All rights reserved